Makana Therapeutics Overview
- Year Founded
-
2009
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Investors
-
2
Makana Therapeutics General Information
Description
Provider of xenotransplantation services intended to solve the organ shortage. The company focuses on commercializing a pipeline of transplantable cells, tissues, and organs for the kidney, heart, lung, liver, blood, and pancreatic islets, enabling patients to provide an abundant supply of donor organs.
Contact Information
Website
www.makanatherapeutics.comCorporate Office
- 370 North East 72nd Terrace
- Miami, FL 33138
- United States
Corporate Office
- 370 North East 72nd Terrace
- Miami, FL 33138
- United States
Makana Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | Completed | Pre-Clinical Trials | ||||
| 1. Grant | 15-Sep-2021 | Completed | Pre-Clinical Trials |
Makana Therapeutics Comparisons
Industry
Financing
Details
Makana Therapeutics Competitors (3)
One of Makana Therapeutics’s 3 competitors is Egenesis, a Venture Capital-Backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Egenesis | Venture Capital-Backed | Cambridge, MA | ||||
| Revivicor | Formerly VC-backed | Blacksburg, VA | ||||
| United Therapeutics | Formerly VC-backed | Silver Spring, MD |
Makana Therapeutics Patents
Makana Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4837130-A1 | Crossmatching products and methods | Pending | 31-Dec-2024 | ||
| AU-2025257802-A1 | Products and methods relating to transplant recipient antibodies bound to donor cell membrane fragments | Pending | 18-Apr-2024 | ||
| WO-2025221920-A1 | Products and methods relating to transplant recipient antibodies bound to donor cell membrane fragments | Pending | 18-Apr-2024 | ||
| AU-2024416329-A1 | Crossmatching products and methods | Pending | 05-Jan-2024 | ||
| WO-2025147461-A1 | Crossmatching products and methods | Inactive | 05-Jan-2024 | A61P37/06 |
Makana Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| KidneyX | Accelerator/Incubator | |||
| Edge (Onalaska) | Corporate Venture Capital |
Makana Therapeutics FAQs
-
When was Makana Therapeutics founded?
Makana Therapeutics was founded in 2009.
-
Where is Makana Therapeutics headquartered?
Makana Therapeutics is headquartered in Miami, FL.
-
What industry is Makana Therapeutics in?
Makana Therapeutics’s primary industry is Biotechnology.
-
Is Makana Therapeutics a private or public company?
Makana Therapeutics is a Private company.
-
What is Makana Therapeutics’s current revenue?
The current revenue for Makana Therapeutics is .
-
Who are Makana Therapeutics’s investors?
KidneyX and Edge (Onalaska) have invested in Makana Therapeutics.
-
Who are Makana Therapeutics’s competitors?
Egenesis, Revivicor, and United Therapeutics are competitors of Makana Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process